Virginia Commonwealth University
Ex vivo reprogramming of tumor-reactive immune cells from FVBN202 mice bearing lung metastatic mammary carcinoma: an immunotherapeutic opportunity revealed against recurrence
Abstract
dc:description.abstractMetastatic breast cancer treatment has seen few advances in recent years, yet treatment resistance continues to rise, causing disease recurrence. A pilot study was performed to determine the efficacy of ex vivo expansion and reprogramming of tumor-reactive immune cells from experimental metastatic tumor-sensitized mice. Also, phenotypic changes in tumors due to metastasis or tumor microenvironment influences were characterized. Metastatic neu+ mouse mammary carcinoma (mMMC) and its distant relapsing neu-antigen-negative variant (mANV) were investigated in FVBN202 mice. Tumor-reactive central memory CD8+ T cells and activated NK/NKT cells were successfully reprogrammed and expanded during 6-day expansion from mMMC- and/or mANV-sensitized mice, resulting in tumor-specific cytotoxicity. mMMC exhibited a flexible neu-expression pattern and acquired stem-like, tumorigenic phenotype following metastasis while mANV remained stable except decreased tumorigenicity. Myeloid-derived suppressor cell (MDSC) levels were not increased. Adoptive cellular therapy (ACT) with reprogrammed tumor-reactive immune cells may prove effective prophylaxis against metastatic or recurrent breast cancer.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- Microbiology & Immunology
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Hall, Charles
- Contributors dc:contributor
-
- Masoud Manjili
Subjects
dc:subject × 16- Metastatic breast cancer
- Immunotherapy
- Her2/neu
- IFN-γ
- CD44+CD24-/low stem-like phenotype
- Tumorigenicity
- Mouse mammary carcinoma
- Invasion
- Common gamma-chain cytokines
- Central memory T cells
- Natural Killer cells
- Natural Killer T cells
- Tumor Microenvironment
- Tumor-specific cytotoxicity
- Prophylactic adoptive cellular therapy
- Medicine and Health Sciences
Rights
dc:rights- Statement dc:rights
-
- © The Author
Identifiers
dc:identifier.*- Identifier
- https://scholarscompass.vcu.edu/etd/3176